866-997-4948(US-Canada Toll Free)

BoneSupport AB - Product Pipeline Analysis, 2018 Update

Published By :

GlobalData

Published Date : Dec 2018

Category :

Pharmaceutical

No. of Pages : 35 Pages

Summary

BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; infection, disease or related to surgical procedures such as benign tumors, fracture malunion and others. The companys major products include bone void filler, vancomycin-eluting synthetic bone substitute and Gentamicin antibiotic eluting bone substitute. BoneSupport also carries out various pre-clinical product candidates intended to promote bone growth. The company markets its products through a network of distributors in Europe and the US. BoneSupport is headquartered in Lund, Sweden.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BoneSupport AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
BoneSupport AB Company Overview 4
BoneSupport AB Company Snapshot 4
BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview 4
BoneSupport AB Pipeline Analysis Overview 6
Business Description 6
BoneSupport AB - Key Facts 6
BoneSupport AB - Major Products and Services 7
BoneSupport AB Pipeline Products by Development Stage 8
BoneSupport AB Ongoing Clinical Trials by Trial Status 10
BoneSupport AB Pipeline Products Overview 12
CERAMENT + Bisphosphonate 12
CERAMENT + Bisphosphonate Product Overview 12
CERAMENT + Bisphosphonates And BMP 13
CERAMENT + Bisphosphonates And BMP Product Overview 13
Cerament + BMP 14
Cerament + BMP Product Overview 14
CERAMENT + BMP And Stem Cells 15
CERAMENT + BMP And Stem Cells Product Overview 15
CERAMENT V 16
CERAMENT V Product Overview 16
CERAMENT V Clinical Trial 17
Cerament|G 18
Cerament|G Product Overview 18
Cerament|G Clinical Trial 19
Gelatin/CERAMENT 21
Gelatin/CERAMENT Product Overview 21
BoneSupport AB - Key Competitors 22
BoneSupport AB - Key Employees 23
BoneSupport AB - Key Employee Biographies 24
BoneSupport AB - Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
BoneSupport AB, Recent Developments 26
Jul 04, 2018: Hakan Johansson to start as BONESUPPORTs CFO at the end of 2018 26
May 29, 2018: BONESUPPORT to Significantly Expand its European Sales Organization 26
May 24, 2018: BONESUPPORT Signs Strategic Agreement with Collagen Matrix to Expand Product Offering in the US 26
May 17, 2018: BONESUPPORT creates its own US Commercial Platform 27
May 04, 2018: BONESUPPORT HOLDING Q1 Interim Report 27
Mar 21, 2018: BONESUPPORT Positive clinical data for CERAMENT G in infection management presented at BLRS 2018 28
Mar 09, 2018: BONESUPPORT to present at Orthopaedic Research Society (ORS) 2018 Annual Meeting 28
Mar 05, 2018: BONESUPPORT to present at Canaccord Musculoskeletal Conference 29
Feb 20, 2018: BoneSupport Q4 and 2017 Year-End Report January December 30
Feb 01, 2018: BONESUPPORT repays outstanding loan from Kreos 31
Appendix 32
Methodology 32
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
BoneSupport AB Pipeline Products and Ongoing Clinical Trials Overview 4
BoneSupport AB Pipeline Products by Equipment Type 5
BoneSupport AB Pipeline Products by Indication 5
BoneSupport AB Ongoing Clinical Trials by Trial Status 5
BoneSupport AB, Key Facts 6
BoneSupport AB, Major Products and Services 7
BoneSupport AB Number of Pipeline Products by Development Stage 8
BoneSupport AB Pipeline Products Summary by Development Stage 9
BoneSupport AB Ongoing Clinical Trials by Trial Status 10
BoneSupport AB Ongoing Clinical Trials Summary 11
CERAMENT + Bisphosphonate - Product Status 12
CERAMENT + Bisphosphonate - Product Description 12
CERAMENT + Bisphosphonates And BMP - Product Status 13
CERAMENT + Bisphosphonates And BMP - Product Description 13
Cerament + BMP - Product Status 14
Cerament + BMP - Product Description 14
CERAMENT + BMP And Stem Cells - Product Status 15
CERAMENT + BMP And Stem Cells - Product Description 15
CERAMENT V - Product Status 16
CERAMENT V - Product Description 16
CERAMENT V - CERAMENTTM|G and V in the Management of Hip and Knee Arthroplasty Revisions (Revision Arthroplasty Italy) 17
Cerament|G - Product Status 18
Cerament|G - Product Description 18
Cerament|G - A Prospective, Randomized Multicenter Controlled Trial of CERAMENT|G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures 19
Cerament|G - CERAMENT lBONE VOID FILLER and Gentamicin Eluting CERAMENT lG for Prophylactic Use in Bone Tumor Patients 19
Cerament|G - CERAMENT/G - Bone Healing and Re-infection Prophylaxis 19
Cerament|G - CERAMENTTM|G and V in the Management of Hip and Knee Arthroplasty Revisions (Revision Arthroplasty Italy) 20
Gelatin/CERAMENT - Product Status 21
Gelatin/CERAMENT - Product Description 21
BoneSupport AB, Key Employees 23
BoneSupport AB, Key Employee Biographies 24
BoneSupport AB, Subsidiaries 25
Glossary 34

List of Figures
BoneSupport AB Pipeline Products by Equipment Type 5
BoneSupport AB Pipeline Products by Development Stage 8
BoneSupport AB Ongoing Clinical Trials by Trial Status 10

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *